Argininosuccinate Synthetase Deficiency (Citrullinemia)

Argininosuccinate Synthetase Deficiency (Citrullinemia) is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
Citrullinemia · Argininosuccinate synthetase deficiency · argininosuccinic acid synthetase deficiency · Argininosuccinate Synthetase Deficient · ASS Deficiency
Indicated drugs

Resolves to

Vocabularies
MeSHM000649001ICD-10E72.23SNOMED CT1149103000MedDRA10058298UMLSC0175683

What you can answer from here — as of November 22, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Argininosuccinate Synthetase Deficiency (Citrullinemia) share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.

Create Account